Antiplatelet agents in cardiology: the choice of therapy

This publication has 22 references indexed in Scilit:

• Acute Hemodynamic Interaction of Aspirin and Ticlopidine With Enalapril
  Circulation, 1998
• Erythrocyte Promotion of Platelet Reactivity Decreases the Effectiveness of Aspirin as an Antithrombotic Therapeutic Modality
  Circulation, 1998
• Interaction Between Enalapril and Aspirin on Mortality After Acute Myocardial Infarction: Subgroup Analysis of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II)
  The American Journal of Cardiology, 1997
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)
  The Lancet, 1996
• Development of aspirin resistance in persons with previous ischemic stroke.
  Stroke, 1994
• Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
  BMJ, 1994
• Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients
  Thrombosis Research, 1993
• Counteraction of the vasodilator effects of enalapril by aspirin in severe heart failure
  Journal of the American College of Cardiology, 1992
• Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
• A Randomized Trial Comparing Ticlopidine Hydrochloride with Aspirin for the Prevention of Stroke in High-Risk Patients
  New England Journal of Medicine, 1989